Novartis acquisition spin-off pioneers RNA therapeutics for the heart

The newly launched Atrium Therapeutics will focus on precision RNA therapeutics for rare, genetic cardiomyopathies.
Business Wire

Atrium Launches AIR, Its New Innovation Lab and Product Incubator, and Unveils ZephyrIQ, a Conversational AI Platform for On-Demand Workforce Insights

NEW YORK--(BUSINESS WIRE)--Atrium, a global Talent Solutions and Extended Workforce Management provider, today announced the launch of Atrium Innovation & Research™ (AIR), a technology innovation lab ...
The Business Journals

StrokeCP, digital health platform developed at Atrium Health Wake Forest Baptist, goes commercial

To continue reading this content, please enable JavaScript in your browser settings and refresh this page. Preview this article 1 min Winston-Salem startup ...
FierceBiotech

Atrium arises from Novartis' Avidity buy with $270M, pair of preclinical cardio candidates

A new biotech has taken flight as a result of Novartis’ red-hot $12 billion acquisition of muscular dystrophy specialist Avidity Biosciences. A spinout planned since that deal’s October announcement ...
Crowdfund Insider

Atrium’s SaaS Platform Aids Real Estate Research

Atrium has launched an enterprise SaaS platform that enables bank and real estate investors and analysts to drill from a bank’s balance sheet to every building it finances—in one click. The company ...
Morningstar

Atrium Launches AIR, Its New Innovation Lab and Product Incubator, and Unveils ZephyrIQ, a Conversational AI Platform for On-Demand Workforce Insights

Atrium Launches AIR, Its New Innovation Lab and Product Incubator, and Unveils ZephyrIQ, a Conversational AI Platform for On-Demand Workforce Insights AIR accelerates Atrium’s product innovation ...